Pruritus in systemic diseases- Cohort with Myeloproliferativeneoplasms (MPN) - PruSearch MP

niklinik Aachen0 个研究点目标入组 60 人开始时间: 2023年1月26日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Diagnosis of a Bcr Abl negative Myeloproliferative Neoplasm according to WHO criteria
•-patients with systemic pruritus (NRS = 3) or Low-itch control group NRS <3 (NRS<3 lasting for more than 6 weeks)
•- Caucasian with skin type I-IV
•- Written informed consent

•- Severe neurological or psychiatric disorders, which may harm the understanding of the informed consent or a lack of linguistic understanding, reading disabilities or disabilities in sight.
•- No consent for registration, storage or processing of personal data
•- No consent for biomaterial donation incl. skin biopsy
•- Chronic pruritus due to other diseases than MPN (e.g. medical eruption,
•psychogenic pruritus)
•- Pregnancy or breastfeeding
•- Neurologic diseases (e.g. Multiple sclerosis, Parkinson's disease, epilepsy) or other diseases, which may affect the study examinations (e.g. HIV infection; pacemaker or implanted defibrillator)
•- Skin lesions (e.g. acute injury, acid burn, cutane injuries in the biopsy region
•- Tendency to abnormal scarring
•- Known allergic reaction to local anesthetics, plaster or latex

发起方

niklinik Aachen